Postdoctoral Researcher

We have an exciting opportunity for a Postdoctoral Researcher to join Professor Anne Kiltie’s group as part of an enthusiastic research team investigating the role of DNA damage signalling and DNA repair as they relate to the treatment of bladder cancer with radiotherapy/chemoradiation and the development of biomarkers of treatment response.
You will have a PhD/DPhil, or have submitted the thesis, in molecular biology, cellular biology, biology or a related science and first author publications in peer-reviewed scientific journals and publication record commensurate with experience. A high level of technical competence and substantial experience in immunohistochemistry, tissue culture techniques and in vivo procedures, and experience in standard molecular biological and biochemical techniques is also an essential requirement of the role.
You will have experience of recent work as a Home Office (or equivalent) Personal Licence holder, preferably cancer-based. A strong knowledge and background in DNA damage signalling/repair would be advantageous.
This is a full-time post and is offered for 3 years in the first instance with the possibility of extension.
All applicants must complete an application form and upload a CV and supporting statement.
The closing date for applications is 12.00 noon on 21 August 2017. Interviews are scheduled for 31 August 2017.
Please note that the University of Oxford's retirement policy is changing. With effect from 1 October 2017, all employees at Grade 8 and above will have a retirement age of 68, and all employees at Grades 6 and 7 will no longer have a set retirement age. Further details are available here:

Closing Date: 
Monday, August 21, 2017 - 12:00
CRUK/MRC Oxford Institute for Radiation and Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.